表紙
市場調查報告書

全球臨床檢驗市場:市場規模,佔有率,及趨勢,及市場區隔預測(類型·各最終用途)

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c, CMP, Liver Panel, Renal Panel, Lipid Panel), By End Use, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 421217
出版日期 內容資訊 英文 90 Pages
商品交期: 2-3個工作天內
價格
全球臨床檢驗市場:市場規模,佔有率,及趨勢,及市場區隔預測(類型·各最終用途) Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c, CMP, Liver Panel, Renal Panel, Lipid Panel), By End Use, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月18日內容資訊: 英文 90 Pages
簡介

本報告提供全球臨床檢驗市場的相關調查,提供市場趨勢,成長和預測,主要交易,各類型·最終用途·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 市場定義
  • 資訊採購
  • 資訊分析
  • 市場定式化和資料的視覺化
  • 資料的檢驗與公開

第2章 摘要整理

  • 市場預測
  • 市場區隔預測
  • 競爭的洞察

第3章 市場變數,趨勢,及規模

  • 市場系預測
  • 滲透與成長預測的製圖
  • 成本結構分析
  • 償付架構
  • 市場動態
  • 市場分析工具
  • PESTEL分析
  • 主要交易和策略性聯盟分析

第4章 競爭情形

  • 全球主要企業,最近的開發,對產業的影響
  • 企業/競爭的類別(主要創新者,市場領導,新興企業)
  • 公開公司
  • 民營企業

第5章 市場分析:各類型

  • 定義和範圍
  • 市場佔有率分析
  • 儀表板
  • 全球市場
  • 市場規模與預測,及趨勢分析
    • 血算
    • HGB / HCT
    • 基礎代謝面板
    • BUN血肌酐
    • 電解質
    • HbA1c
    • 綜合代謝面板
    • 肝面板
    • 腎面板
    • 脂質面板

第6章 市場分析:各最終用途

  • 定義和範圍
  • 市場佔有率分析
  • 儀表板
  • 全球市場
  • 市場規模與預測,及趨勢分析
    • 中央研究所
    • 主要診所

第7章 市場分析:各地區

  • 市場概述
  • 地區的市場佔有率和主要企業
  • 要因別SWOT分析(政治,法律,經濟,技術性)
  • 市場規模,預測,趨勢分析

第8章 企業簡介

  • 策略架構

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-361-4

The global clinical laboratory tests market size is expected to reach USD 304.9 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. Introduction of new solutions for minimizing errors and maximizing efficiency is anticipated to boost the overall market growth.

Presence of favorable reimbursement plans for laboratory tests is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association (ACLA), these tests are reimbursed by Medicare payees either under the Physician Fee Schedule or Clinical Laboratory Fee Schedule based on the nature of service.

According to an article published in Forbes, in 2018, the new clinical lab fee schedule reduced their overall payments by 10% as compared to 2017 for tests that represent nearly two-thirds of Medicare's outlays for laboratory tests.

In addition, growing demand for early detection of several diseases is anticipated to drive the clinical laboratory tests market over the forecast period. For instance, biochips are used for preparing thousands of DNA, RNA, or protein samples that can be processed on a single chip at the same time. According to an article published in the American Clinical Laboratory Association, more than 7 billion clinical laboratory examinations are performed each year in U.S.

Presence of major players such as QIAGEN, Laboratory Corporation of America Holdings, Siemens Healthcare GmbH, Quest Diagnostics Incorporated, and Abbott is expected to fuel the market growth. These companies are involved in undertaking initiatives such as product development, strategic collaborations, and regional expansion.

In November 2019, QIAGEN entered into a strategic agreement with Laboratory Corporation of America Holdings to extend its existing QIAGEN Clinical Insights license. Moreover, in August 2018, QIAGEN collaborated with SRL, Inc., Japan's largest clinical testing lab company, to prepare for the introduction of novel companion diagnostic tests along with new drug approvals.

Further key findings from the report suggest:

In 2019, basic metabolic panel dominated the type segment owing to the increasing prevalence of lifestyle-induced diseases

Lipid panel is projected to register a CAGR of 8.0% over the forecast period owing to rising incidences of cardiovascular disorders globally

In 2019, hepatitis dominated the liver panel segment whereas liver cirrhosis is estimated to be the fastest-growing sub-segment over the forecast period

Central laboratories dominated the overall market in 2019 owing to the expansion of key laboratories such as Q2 Solutions and Pharmaceutical Product Development, LLC

Primary clinics is anticipated to register a significant CAGR of 7.6% from 2020 to 2027 owing to advancements such as portable and rapid diagnostic tests

North America dominated the global market in 2019 owing to the increasing geriatric population and high disease prevalence

Asia Pacific is projected to be the fastest-growing market over the forecast period owing to improving healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Market definition
  • 1.3. Information procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third-party perspectives
    • 1.3.4. Primary research
  • 1.4. Information analysis
    • 1.4.1. Data analysis models
  • 1.5. Market formulation & data visualization
  • 1.6. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Clinical Laboratory Tests Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Cost Structure Analysis
  • 3.4. Reimbursement Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market driver analysis
      • 3.5.1.1. Rising geriatric population base
      • 3.5.1.2. Growing prevalence of target diseases
      • 3.5.1.3. Introduction of innovative solutions
      • 3.5.1.4. Rising demand for early disease detection
    • 3.5.2. Market restraint analysis
      • 3.5.2.1. Presence of ambiguous regulatory framework
  • 3.6. Clinical Laboratory Tests Market Analysis Tools
    • 3.6.1. Industry analysis - Porter's
      • 3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
      • 3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
      • 3.6.1.3. Substitution Threat: Low due to no/less external substitutes
      • 3.6.1.4. Threat from new entrants: Moderate due to brand recognition of the existing players
      • 3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
  • 3.7. PESTEL Analysis
    • 3.7.1. Political landscape
    • 3.7.2. Environmental landscape
    • 3.7.3. Social landscape
    • 3.7.4. Technology landscape
    • 3.7.5. Legal landscape
  • 3.8. Major Deals & Strategic Alliances Analysis
    • 3.8.1. Joint ventures
    • 3.8.2. Mergers & acquisitions
    • 3.8.3. Licensing & partnership
    • 3.8.4. Technology collaborations
    • 3.8.5. Strategic divestments

Chapter 4. Clinical Laboratory Tests Market - Competitive Analysis

  • 4.1. Recent developments & impact analysis, by key market participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Public Companies
    • 4.3.1. Company market position analysis
    • 4.3.2. Company market share/ranking, by region
    • 4.3.3. Competitive dashboard analysis
    • 4.3.4. Market differentiators
    • 4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
  • 4.4. Private Companies
    • 4.4.1. List of key emerging companies
    • 4.4.2. Regional network map
    • 4.4.3. Company market position analysis

Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Type market share analysis, 2019 & 2027
  • 5.3. Type Dashboard
  • 5.4. Global Clinical Laboratory Test Market, by Type, 2016 to 2027
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 5.5.1. Complete blood count
    • 5.5.2. HGB/HCT testing
    • 5.5.3. Basic metabolic panel testing
    • 5.5.4. BUN creatinine testing
    • 5.5.5. Electrolytes testing
    • 5.5.6. HbA1c testing
    • 5.5.7. Comprehensive metabolic panel testing
    • 5.5.8. Liver panel testing
      • 5.5.8.1. Hepatitis
      • 5.5.8.2. Bile duct obstruction
      • 5.5.8.3. Liver Cirrhosis
      • 5.5.8.4. Liver Cancer
      • 5.5.8.5. Bone disease
      • 5.5.8.6. Autoimmune disorders
      • 5.5.8.7. Others
    • 5.5.9. Renal panel testing
    • 5.5.10. Lipid panel testing

Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. End-use market share analysis, 2019 & 2027
  • 6.3. End-use Dashboard
  • 6.4. Global Clinical Laboratory Test Market, by End-use, 2016 to 2027
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 6.5.1. Central Laboratories
      • 6.5.1.1. Complete blood count
      • 6.5.1.2. HGB/HCT testing
      • 6.5.1.3. Basic metabolic panel testing
      • 6.5.1.4. BUN creatinine testing
      • 6.5.1.5. Electrolytes testing
      • 6.5.1.6. HbA1c testing
      • 6.5.1.7. Comprehensive metabolic panel testing
      • 6.5.1.8. Liver panel testing
      • 6.5.1.9. Renal panel testing
      • 6.5.1.10. Lipid panel testing
    • 6.5.2. Primary Clinics
      • 6.5.2.1. Complete blood count
      • 6.5.2.2. HGB/HCT testing
      • 6.5.2.3. Basic metabolic panel testing
      • 6.5.2.4. BUN creatinine testing
      • 6.5.2.5. Electrolytes testing
      • 6.5.2.6. HbA1c testing
      • 6.5.2.7. Comprehensive metabolic panel testing
      • 6.5.2.8. Liver panel testing
      • 6.5.2.9. Renal panel testing
      • 6.5.2.10. Lipid panel testing

Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis, by Type, End-Use and End-Use by Type

  • 7.1. Regional Market Snapshot
  • 7.2. Regional Market Share and Leading Players, 2019
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.4.1. North America
      • 7.4.1.1. U.S.
      • 7.4.1.2. Canada
    • 7.4.2. Europe
      • 7.4.2.1. U.K.
      • 7.4.2.2. Germany
      • 7.4.2.3. Spain
      • 7.4.2.4. France
      • 7.4.2.5. Italy
      • 7.4.2.6. Russia
    • 7.4.3. Asia Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. South Korea
      • 7.4.3.5. Singapore
      • 7.4.3.6. Australia
    • 7.4.4. South America
      • 7.4.4.1. Brazil
      • 7.4.4.2. Mexico
      • 7.4.4.3. Argentina
    • 7.4.5. Middle East Africa
      • 7.4.5.1. South Africa
      • 7.4.5.2. Saudi Arabia
      • 7.4.5.3. UAE

Chapter 8. Company Profiles

  • 8.1. Strategic Framework
    • 8.1.1. Abbott
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial framework
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. ARUP Laboratories
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial framework
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. OPKO Health, Inc.
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial framework
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Bioscientia Institut fur Medizinische Diagnostik GmbH
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial framework
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Charles River
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial framework
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Neogenomics Laboratories, Inc. (Clarient, Inc.)
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial framework
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Genoptix, Inc.
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial framework
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Healthscope
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial framework
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Labco S.A
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial framework
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Laboratory Corporation of America Holdings (LabCorp)
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial framework
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. QIAGEN
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial framework
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Quest Diagnostics
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial framework
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. Siemens Healthcare Private Limited
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial framework
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. Sonic Healthcare
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial framework
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
    • 8.1.15. Fresenius Medical Care Holdings, Inc.
      • 8.1.15.1. Company overview
      • 8.1.15.2. Financial framework
      • 8.1.15.3. Product benchmarking
      • 8.1.15.4. Strategic initiatives
    • 8.1.16. Merck KgaA
      • 8.1.16.1. Company overview
      • 8.1.16.2. Financial framework
      • 8.1.16.3. Product benchmarking
      • 8.1.16.4. Strategic initiatives
    • 8.1.17. Tulip Diagnostics
      • 8.1.17.1. Company overview
      • 8.1.17.2. Financial framework
      • 8.1.17.3. Product benchmarking
      • 8.1.17.4. Strategic initiatives
    • 8.1.18. Biosino Bio-technology and Science Inc.
      • 8.1.18.1. Company overview
      • 8.1.18.2. Financial framework
      • 8.1.18.3. Product benchmarking
      • 8.1.18.4. Strategic initiatives

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 North America Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 3 North America Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 4 North America Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 5 North America Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 6 North America Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 7 U.S. Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 8 U.S. Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 9 U.S. Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 10 U.S. Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 11 Canada Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 12 Canada Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 13 Canada Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 14 Canada Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 15 Europe Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 16 Europe Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 17 Europe Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 18 Europe Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 19 Europe Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 20 U.K. Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 21 U.K. Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 22 U.K. Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 23 U.K. Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 24 Germany Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 25 Germany Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 26 Germany Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 27 Germany Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 28 France Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 29 France Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 30 France Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 31 France Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 32 Italy Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 33 Italy Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 34 Italy Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 35 Italy Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 36 Spain Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 37 Spain Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 38 Spain Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 39 Spain Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 40 Russia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 41 Russia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 42 Russia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 43 Russia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 44 Asia Pacific Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 45 Asia Pacific Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 46 Asia Pacific Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 47 Asia Pacific Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 48 Asia Pacific Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 49 Japan Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 50 Japan Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 51 Japan Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 52 Japan Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 53 China Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 54 China Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 55 China Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 56 China Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 57 India Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 58 India Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 59 India Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 60 India Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 61 Australia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 62 Australia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 63 Australia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 64 Australia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 65 South Korea Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 66 South Korea Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 67 South Korea Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 68 South Korea Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 69 Singapore Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 70 Singapore Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 71 Singapore Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 72 Singapore Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 73 Latin America Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 74 Latin America Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 75 Latin America Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 76 Latin America Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 77 Latin America Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 78 Mexico Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 79 Mexico Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 80 Mexico Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 81 Mexico Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 82 Brazil Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 83 Brazil Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 84 Brazil Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 85 Brazil Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 86 Argentina Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 87 Argentina Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 88 Argentina Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 89 Argentina Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 90 MEA Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 91 MEA Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 92 MEA Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 93 MEA Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 94 MEA Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 95 South Africa Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 96 South Africa Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 97 South Africa Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 98 South Africa Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 99 UAE Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 100 UAE Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 101 UAE Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 102 UAE Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 103 Saudi Arabia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 104 Saudi Arabia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 105 Saudi Arabia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 106 Saudi Arabia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Summary
  • Fig. 4 Market Segmentation & Scope
  • Fig. 5 Market Size and Growth Prospects
  • Fig. 6 Global Clinical Laboratory Tests- Key Market Driver Analysis
  • Fig. 7 Global Clinical Laboratory Tests Market - Key Market Restraint Analysis
  • Fig. 8 Penetration & Growth Prospect Mapping
  • Fig. 9 Global Clinical Laboratory Tests Market - Porter's Analysis
  • Fig. 10 Global Clinical Laboratory Tests Market - PESTEL Analysis
  • Fig. 11 Global Clinical Laboratory Tests Market Type Outlook Key Takeaways
  • Fig. 12 Global Clinical Laboratory Tests Market: Type Movement Analysis
  • Fig. 13 Complete Blood Count Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 14 HGB/HCT Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 15 Basic Metabolic Panel Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 16 Bun Creatinine Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 17 Electrolytes Testing Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 19 Hba1c Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 20 Comprehensive Metabolic Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 21 Liver Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 22 Hepatitis Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 23 Bile Duct Obstruction Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 24 Liver Cirrhosis Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 25 Liver Cancer Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 26 Bone Disease Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 27 Autoimmune Disorder Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 28 Others Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 29 Renal Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 30 Lipid Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 31 Global Clinical Laboratory Tests Market End-Use Outlook Key Takeaways
  • Fig. 32 Global Clinical Laboratory Tests Market: End-Use Movement Analysis
  • Fig. 33 Central Laboratories Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 34 Primary Clinics Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 Global Clinical Laboratory Tests Market: Regional Movement Analysis
  • Fig. 37 North America Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 38 U.S. Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 39 Canada Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 40 Europe Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 41 U.K. Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 42 Germany Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 43 France Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 44 Spain Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 45 Italy Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 46 Russia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 47 Asia Pacific Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 48 Japan Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 49 China Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 50 India Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 51 South Korea Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 52 Singapore Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 53 Australia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 54 Latin America Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 55 Brazil Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 56 Mexico Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 57 Argentina Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 58 MEA Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 59 South Africa Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 60 UAE Market, 2016 - 2027 (USD Billion)
  • Fig. 61 Saudi Arabia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 62 Strategy Framework